Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Valocor Therapeutics logo — Innovative therapies for dermatological conditions with unme...

Valocor Therapeutics

Innovative therapies for dermatological conditions with unmet medical needs

Founded 2008 Series Unknown Biotechnology

General Information

Company Name Valocor Therapeutics
Founded Year 2008
Industries Biotechnology
Funding Stage Series Unknown
Social

Get notified when Valocor Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Valocor Therapeutics

Valocor Therapeutics is a clinical stage biotech company focused on creating innovative therapies to address unmet needs in dermatology. Founded in 2008, the company's product line includes Lemuteporfin, a selective topical photodynamic therapy for severe acne; VAL-001, a topical sebum inhibitor for acne and sebaceous gland hyperactivity; VAL-002, a small-molecule kinase inhibitor for chronic inflammatory skin diseases; and VAL-003, a kinase inhibitor with dual melanin-stimulating and immune-modulating properties. Headquartered in Vancouver, Canada, Valocor Therapeutics received a Venture Round investment from Matrix Asset Management on 25 May 2010. With its slogan "Innovative therapies for dermatological conditions with unmet medical needs," Valocor Therapeutics is poised to make a substantial impact in the biotechnology industry.

Taxonomy: Biotech, Dermatology, Clinical stage, Therapies, Acne treatment, Sebaceous glands, Topical photodynamic therapy, Sebum inhibitor, Chronic inflammatory skin diseases, Kinase inhibitor, Melanin-stimulating, Immune-modulating, Start-up, Investment opportunity

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
25 May 2010

Valocor Therapeutics Alternatives & Competitors

Valocor Therapeutics vs
Altheos
Altheos

Pioneering novel treatments with promising small molecule drugs for glaucoma, supported by significa...

Series A
Biotechnology, Health Care
Valocor Therapeutics vs
AlloMek Therapeutics LLC
AlloMek Therapeutics LLC

Dedicated to advancing cancer treatment through innovative MEK kinase inhibitors.

Pre Seed
1 employees
Biotechnology, Health and Wellness
Valocor Therapeutics vs
Chromis Therapeutics
Chromis Therapeutics United States

Chromis Therapeutics, Inc. is a San Diego-based biopharmaceutical company, focused on the developmen...

Seed
51-200 employees
Biotechnology, Health Care

FAQ About Valocor Therapeutics

Innovative therapies for dermatological conditions with unmet medical needs
Valocor Therapeutics was founded in 2008.
Valocor Therapeutics operates in the following industries: Biotechnology.
Valocor Therapeutics has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to Valocor Therapeutics include Altheos, AlloMek Therapeutics LLC, Chromis Therapeutics, Treadwell Therapeutics, Inc., Tyrogenex. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Valocor Therapeutics and Altheos are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Valocor Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy